Literature DB >> 17172701

Depletion of high-abundance proteins in plasma by immunoaffinity subtraction for two-dimensional difference gel electrophoresis analysis.

Verónica M Dardé1, Maria G Barderas, Fernando Vivanco.   

Abstract

Blood plasma is believed the most complex human-derived proteome, containing other tissue proteome subsets. Almost all body cells communicate with the plasma, either directly or through tissues or biological fluids, and many of these cells release at least a part of their content into the plasma upon damage or death. A comprehensive, systematic characterization of the plasma proteome in the healthy and diseased states will greatly facilitate the development of biomarkers for early disease detection, clinical diagnosis, and therapy. However, the characterization of human plasma proteome is a very complicated task, owing to the wide dynamic range of concentration that separates the most abundant proteins and the less common ones (10-12 orders of magnitude). The removal of its predominant proteins by affinity chromatography using an FPLC system improves the presence of low-abundance proteins in two-dimensional gel electrophoresis (2DE). The "Multiple Affinity Removal System" (Agilent Technologies) retains albumin, IgG, IgA, haptoglobin, transferrin, and antitrypsin with high specificity and reproducibility. After depletion, we have independently analyzed the flow-through (low-abundance proteins), and the retained fractions, by 2DE (4.0-7.0 pH range). Image analysis of the stained gels revealed that more than 300 spots appeared in the retained fraction and about 1800 spots appeared in the nonretained fraction. This methodology is a valuable tool for clinical proteomics, because its reproducibility allows comparative studies and quantitative analysis by 2DE or two-dimensional differential gel electrophoresis of plasma or sera samples from subjects with different pathological or physiological conditions. In addition, the method allows the comparison of experimental results from different laboratories.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17172701     DOI: 10.1385/1-59745-214-9:351

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  A depletion strategy for improved detection of human proteins from urine.

Authors:  Mark M Kushnir; Peter Mrozinski; Alan L Rockwood; David K Crockett
Journal:  J Biomol Tech       Date:  2009-04

2.  Identification of novel diagnostic serum biomarkers for Chagas' disease in asymptomatic subjects by mass spectrometric profiling.

Authors:  Momar Ndao; Terry W Spithill; Rebecca Caffrey; Hongshan Li; Vladimir N Podust; Regis Perichon; Cynthia Santamaria; Alberto Ache; Mark Duncan; Malcolm R Powell; Brian J Ward
Journal:  J Clin Microbiol       Date:  2010-01-13       Impact factor: 5.948

Review 3.  Metabolomic profiling for identification of novel potential biomarkers in cardiovascular diseases.

Authors:  Maria G Barderas; Carlos M Laborde; Maria Posada; Fernando de la Cuesta; Irene Zubiri; Fernando Vivanco; Gloria Alvarez-Llamas
Journal:  J Biomed Biotechnol       Date:  2011-01-02

4.  Plasma Proteomic Profiling in Hereditary Breast Cancer Reveals a BRCA1-Specific Signature: Diagnostic and Functional Implications.

Authors:  Domenica Scumaci; Laura Tammè; Claudia Vincenza Fiumara; Giusi Pappaianni; Antonio Concolino; Emanuela Leone; Maria Concetta Faniello; Barbara Quaresima; Enrico Ricevuto; Francesco Saverio Costanzo; Giovanni Cuda
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

5.  Proteomic analysis of serum, plasma, and lymph for the identification of biomarkers.

Authors:  Zhaojing Meng; Timothy D Veenstra
Journal:  Proteomics Clin Appl       Date:  2007-07-13       Impact factor: 3.494

6.  Proteomic Biomarkers of Atherosclerosis.

Authors:  F Vivanco; L R Padial; V M Darde; F de la Cuesta; G Alvarez-Llamas; Natacha Diaz-Prieto; M G Barderas
Journal:  Biomark Insights       Date:  2008-03-12

7.  Remote ischemic preconditioning (RIPC) modifies plasma proteome in humans.

Authors:  Michele Hepponstall; Vera Ignjatovic; Steve Binos; Paul Monagle; Bryn Jones; Michael H H Cheung; Yves d'Udekem; Igor E Konstantinov
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

8.  Differentiation of type 2 diabetes mellitus with different complications by proteomic analysis of plasma low abundance proteins.

Authors:  Shu-Hui Yeh; Wan-Ching Chang; Hau Chuang; Hui-Cheng Huang; Rue-Tsuan Liu; Kuender D Yang
Journal:  J Diabetes Metab Disord       Date:  2016-07-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.